Universita' Degli Studi Di Roma La Sapienza
- Address
- Via Firenze, 04019 Terracina, Italy
Skin and Connective Tissue Diseases
At Universita' Degli Studi Di Roma La Sapienza, research in skin and connective tissue diseases focuses on hidradenitis suppurativa, a chronic inflammatory condition that can cause painful lesions and recurring flare-ups. These studies are aimed at evaluating new treatment options and understanding how well they work over time for people living with moderate to severe disease.
- Testing a new therapy for hidradenitis suppurativa
- Assessing long-term treatment safety in hidradenitis suppurativa
- Studying treatment effectiveness in patients with persistent inflammatory skin disease
The site contributes to both initial treatment evaluation and longer-term follow-up, helping build evidence for better management of this difficult skin condition.
Eye Diseases
Clinical research in eye diseases at this site centers on open-angle glaucoma and ocular hypertension, two conditions linked to elevated eye pressure and risk of vision loss. The trials are designed to understand how well treatment can control eye pressure over time, especially for people who cannot use standard eye drops consistently or effectively.
- Evaluating eye pressure control in open-angle glaucoma
- Studying treatment response in ocular hypertension
- Assessing the duration of effect of a sustained eye treatment
This line of research supports improved disease management and may offer more practical options for patients who need long-lasting control of intraocular pressure.
Bacterial Infections and Mycoses
The site also participates in research linked to bacterial infections and mycoses, reflecting the inflammatory and infection-related aspects that can be relevant in hidradenitis suppurativa. These studies aim to clarify the safety and effectiveness of emerging therapies for a condition that often has a complex and recurring course.
- Exploring new therapeutic approaches for chronic inflammatory skin disease
- Monitoring safety in longer-term treatment use
- Supporting evidence development for future care strategies
With a small but focused portfolio of clinical trials, Universita' Degli Studi Di Roma La Sapienza is contributing to research that may improve care for both skin and eye disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Universita' Degli Studi Di Roma La Sapienza
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension | AbbVie Deutschland GmbH & Co. KG | Phase III | Not Recruiting | Aug 2019 | Jul 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bimatoprost | 1 | Unknown | 2019-08-02 | 2019-08-02 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.